The bill amends 5 U.S.C. §2302(a)(2)(C)(i) to add an explicit cross‑reference bringing ‘‘non‑disclosure policy, form, or agreement described under subsection (b)(13)’’ within the statute’s existing prohibition on gagging disclosures of wrongdoing. Put simply: federal agencies cannot rely on NDAs or similar instruments referenced in §2302(b)(13) to stop employees from making protected disclosures.
This change is surgical and narrow: it does not create new investigatory bodies or remedies, but it expands the textual reach of the existing anti‑gag rule. For compliance officers and agency counsel, the immediate consequence is a likely need to review standard forms, settlement agreements, and confidentiality templates to remove or reword clauses that could be read to bar protected whistleblower disclosures.
At a Glance
What It Does
The bill inserts the phrase ‘‘or in the case of a non‑disclosure policy, form, or agreement described under subsection (b)(13)’’ into 5 U.S.C. §2302(a)(2)(C)(i), explicitly covering certain NDAs and similar instruments under the statute’s prohibition on restricting disclosures. It does not alter the statutory enforcement framework or add new penalties.
Who It Affects
Directly affects federal agencies, agency counsel, HR and settlement teams that draft or use confidentiality agreements, and federal employees who sign those documents. It does not on its face change obligations for private‑sector contractors unless their agreements are incorporated into federal employment terms.
Why It Matters
By textually extending §2302’s anti‑gag protection to specified non‑disclosure instruments, the bill reduces the risk that agencies will hide wrongdoing behind confidentiality clauses and creates a compliance trigger point for agencies to revise existing templates and training materials.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill makes a single, targeted statutory change: it amends the list of materials that cannot lawfully be used to silence a federal employee by adding non‑disclosure policies, forms, and agreements referenced in 5 U.S.C. §2302(b)(13). That means an agency cannot point to a settlement confidentiality clause, standard employment confidentiality form, or other written non‑disclosure instrument described under the cross‑reference and say an employee is barred from speaking up about wrongdoing covered by §2302.
Because the bill amends an existing prohibition rather than creating a new cause of action or remedy, it works through the same enforcement mechanisms already in place under Title 5: employees will continue to pursue whistleblower claims under the existing statutory regime, but defendants (agencies or supervisory officials) can no longer rely on the newly referenced NDAs as a lawful justification for silencing disclosures. Practically, agencies that use standard confidentiality language in personnel actions and settlements will need to reassess those clauses to avoid conflict with the expanded statutory text.The amendment also raises predictable operational questions.
Agencies will need to inventory written policies and forms identified under §2302(b)(13) and decide whether to revise, disclaim applicability to protected disclosures, or add narrowly tailored language preserving privacy or classified‑information protections while affirming whistleblower rights. Expect legal challenges over the scope of the new cross‑reference — for example, whether particular settlement provisions or limited‑scope confidentiality terms fall inside or outside the protected category — but the bill’s plain‑text approach strengthens the argument that such NDAs cannot lawfully gag disclosures of wrongdoing.
The Five Things You Need to Know
The bill amends 5 U.S.C. §2302(a)(2)(C)(i) by inserting ‘‘or in the case of a non‑disclosure policy, form, or agreement described under subsection (b)(13)’’ after ‘‘(D)’’.
It explicitly brings certain non‑disclosure policies, forms, and agreements described under §2302(b)(13) within the statute’s ban on restricting whistleblower disclosures.
The bill does not create a new enforcement mechanism or new penalties; it operates by expanding the existing statutory prohibition in Title 5.
Agencies that use confidentiality clauses in settlements, employment forms, or internal policies will need to revise those instruments to avoid being read as unlawfully restricting disclosures covered by §2302.
The Act is short and narrowly targeted: it changes a single clause of Title 5 rather than overhauling whistleblower statute structure or remedies.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Gives the statute the public name ‘‘Whistleblower Anti‑Gag Act of 2026.’' This is a conventional short‑title provision and has no substantive legal effect beyond labeling the Act for citation and reference.
Amendment to 5 U.S.C. §2302(a)(2)(C)(i) — explicit inclusion of certain NDAs
This is the operative change: the bill inserts an explicit cross‑reference so that ‘‘non‑disclosure policy, form, or agreement described under subsection (b)(13)’’ falls within the list of instruments that cannot lawfully restrict disclosures protected by the statute. Practically, this removes ambiguity agencies might have used to argue that confidentiality instruments — including settlement clauses and standard NDA language — can bar whistleblowing when the subject matter is covered by §2302. The amendment is textual and limited to the language of the existing prohibition; it does not specify new remedies or procedures for enforcement.
Triggers for policy review, training, and litigation over scope
Although brief, the amendment creates immediate compliance tasks: agencies must identify policies and templates that match the description in §2302(b)(13) and modify language that could be read as gagging protected disclosures. Counsel will need to craft alternative confidentiality language that preserves legitimate privacy, classified, or proprietary protections while explicitly exempting whistleblower disclosures. Because the bill does not define procedural steps for those revisions, expect disputes over whether a particular clause falls within the covered category — and subsequent litigation testing the amendment’s scope.
This bill is one of many.
Codify tracks hundreds of bills on Government across all five countries.
Explore Government in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Federal employees and potential whistleblowers — gain clearer statutory protection against being silenced by NDAs or agency confidentiality instruments described under §2302(b)(13), lowering the legal risk of reporting wrongdoing.
- Congressional oversight and inspectors general — strengthened access to employee testimony and documentary evidence when confidentiality instruments can no longer be read to bar disclosures of wrongdoing.
- Public accountability organizations and watchdogs — fewer agency instruments will be available to shield misconduct, improving transparency in investigations and oversight.
Who Bears the Cost
- Federal agency HR, legal, and settlement offices — must review and revise existing templates, settlement language, and policies to ensure compliance, incurring legal and administrative costs.
- Agency leadership and supervisors — loss of a tool (broad confidentiality clauses) that agencies sometimes use to manage reputational or personnel risks, which may complicate settlement negotiations and internal discipline processes.
- Agency budgets and general counsel offices — potential increase in litigation and claim disputes as parties test the new cross‑reference and its boundaries, imposing legal costs and staff time.
Key Issues
The Core Tension
The central dilemma is balancing two legitimate interests: preventing agencies from using NDAs to silence reports of wrongdoing, versus preserving the ability to protect classified information, individual privacy, and sensitive proprietary data through confidentiality instruments; the amendment favors clearer whistleblower protection but leaves unresolved how to protect genuinely sensitive information without reintroducing de facto gagging.
The amendment is narrowly drafted but raises several practical and legal tensions. First, it does not resolve how to reconcile whistleblower protections with legitimate confidentiality interests — for example classified national security information, protected personal data under the Privacy Act, or proprietary contractor information.
The text does not add carve‑outs or procedures for handling such conflicts; agencies will need to rely on existing statutes and classification rules to limit disclosures, which could produce inconsistent practices and case‑by‑case litigation.
Second, the bill’s effectiveness depends on the interpretation of the phrase it imports from §2302(b)(13). If that subsection is narrowly defined, the amendment’s reach will be limited; if courts read it broadly, agencies may find long‑standing confidentiality instruments invalidated.
Because the Act does not change remedies or enforcement mechanics, disputes about scope will play out under the existing whistleblower adjudication processes, potentially increasing docket pressure on offices that adjudicate whistleblower claims.
Finally, the bill applies to federal employees and the non‑disclosure instruments described under the cross‑reference; it does not explicitly alter the status of NDAs used in contractor or contractor‑employee relationships. That leaves open questions about practical workarounds (e.g., greater reliance on contractor confidentiality) and whether further legislative action will be needed to address those gaps.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.